πŸ‡ΊπŸ‡Έ FDA
Patent

US 7132422

Sodium channel modulators

granted A61KA61K31/135A61K31/401

Quick answer

US patent 7132422 (Sodium channel modulators) held by Theravance, Inc. expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/135, A61K31/401, A61K31/4152, A61K31/417